Although approximately 12% of women in general population develop breast cancer all through their life, 72% of women with pathogenic BRCA1 mutation and 69% of women with pathogenic BRCA2 mutation are diagnosed with breast cancer at a stage of life. The gene discussed is BRCA2; the disease is breast carcinoma.